Does Medicare Cover Ozempic in 2026? Coverage, Cost & Type 2 Diabetes Rules

If you enrolled in Medicare to cover your Ozempic, it will depend on your doctor's reason for prescribing it. Medicare has reimbursed for the drug for years for one use, and 2026 was when it saw the largest price increase in the drug's history.

Medicare does cover the cost of Ozempic in 2026, but not for weight loss; it is only for conditions such as type 2 diabetes. Coverage is provided by Medicare Part D or a Medicare Advantage plan that also includes drug coverage and most plans will require a diagnosis of type 2 diabetes for prior authorization. The federal pricing announcement made in November 2025 has resulted in Medicare paying a negotiated price of $245 per month for the drug, and beneficiaries are responsible for $50 per month in copays.

The diabetes rule is fragging thousands of beneficiaries each year, and being knowledge of exactly how it works can save you a denied claim and a $1000 pharmacy bill.

Does Medicare Cover Ozempic for Type 2 Diabetes?

Yes. Ozempic (semaglutide) is FDA-approved for type 2 diabetes and just about all Medicare Part D and Medicare Advantage prescription drug plans have it listed on the formulary for this condition. According to KFF, GLP-1 drugs are one of the biggest categories under Medicare's drug program, accounting for $5.7 billion in expenditures in 2022.

Most plans have a preferred brand list and will require prior authorization for Ozempic. A diagnosis of type 2 diabetes is usually required and most plans will want to see you have recently been diagnosed with diabetes and have had an A1C test, as well as that you tried metformin first. Authorizations typically expire after 12 months, and must be renewed.

Also, since January 2025, FDA approved Ozempic to lower the likelihood of worsening of kidney disease in adults with type 2 diabetes and chronic kidney disease. That second sign will provide another path for the prescriber, but the diabetes diagnosis will be the basis for Medicare coverage.

Does Medicare Cover Ozempic for Weight Loss?

No, and that's the most important rule! Weight-loss drugs have been covered by federal law outside of Medicare Part D for a long time, and AMCP's federal policy analysis confirms that the final 2026 Medicare rules continue to exclude weight-loss drugs.

The new Medicare GLP-1 Bridge pilot (which starts July 1, 2026, and includes some weight-loss medications for the first time) does not include Ozempic. The pilot will be for the drugs Wegovy, Zepbound KwikPen and a new oral pill called Foundayo, all of which are FDA-approved to treat obesity, NPR reports. Ozempic is approved for diabetes, so it is not in the pilot.

For weight loss, the realistic options are Wegovy or Zepbound as part of the Bridge pilot (if eligible) or self-pay, as detailed below in this article.

What Does Ozempic Cost on Medicare in 2026?

This year was a huge improvement in price. In a December 2025 deal reported by Axios between the federal government and Novo Nordisk, Medicare now reimburses at a rate of $245 per month for Ozempic, which is about a quarter of its previously reported list price of near $1,000. Beneficiary copays will not exceed $50 per month.

The actual cost will depend on the phase of your plan. Once you've met your Part D deductible (up to $615 in 2026), you will cover your plan's copay, capped at $50 for GLP-1s. The $2,100 annual maximum out-of-pocket cost for all Part D drugs in 2026 also covers heavy Part D drug users. Those eligible for Extra Help pay even less, typically less than $12 per fill.

How to Get Ozempic Approved by Medicare

Getting approval is a paperwork exercise more than a medical battle when you have type 2 diabetes. Confirm Ozempic is on your plan's formulary using the Medicare Plan Finder at Medicare.gov. Ask your doctor to submit the prior authorization with your diabetes diagnosis code, recent A1C, and any prior medication history the plan requests. Most decisions come back within 72 hours, or 24 hours for expedited requests.

If you're denied, you have appeal rights. The first appeal (redetermination) succeeds often when the denial was a missing-paperwork issue. Your doctor can also request a formulary exception if your plan prefers a different GLP-1 first.